COMPARATIVE STUDY ON PHARMACOVIGILANCE AND PHARMACOECONOMIC EVALUATION OF CONVENTIONAL AND BIOLOGICAL DMARD THERAPY IN RHEUMATOID ARTHRITIS
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease requiring long-term treatment. Conventional disease-modifying antirheumatic drugs remain the foundation of therapy, whereas biological DMARDs are important for patients requiring treatment escalation. Their safety monitoring and economic burden are...